Queen's University Belfast, Centre for Cancer Research and Cell Biology, Belfast BT9 7BL, UK.
Comput Biol Chem. 2010 Dec;34(5-6):284-92. doi: 10.1016/j.compbiolchem.2010.09.005. Epub 2010 Oct 8.
Over the past ten years, a variety of microRNA target prediction methods has been developed, and many of the methods are constantly improved and adapted to recent insights into miRNA-mRNA interactions. In a typical scenario, different methods return different rankings of putative targets, even if the ranking is reduced to selected mRNAs that are related to a specific disease or cell type. For the experimental validation it is then difficult to decide in which order to process the predicted miRNA-mRNA bindings, since each validation is a laborious task and therefore only a limited number of mRNAs can be analysed. We propose a new ranking scheme that combines ranked predictions from several methods and - unlike standard thresholding methods - utilises the concept of Pareto fronts as defined in multi-objective optimisation. In the present study, we attempt a proof of concept by applying the new ranking scheme to hsa-miR-21, hsa-miR-125b, and hsa-miR-373 and prediction scores supplied by PITA and RNAhybrid. The scores are interpreted as a two-objective optimisation problem, and the elements of the Pareto front are ranked by the STarMir score with a subsequent re-calculation of the Pareto front after removal of the top-ranked mRNA from the basic set of prediction scores. The method is evaluated on validated targets of the three miRNA, and the ranking is compared to scores from DIANA-microT and TargetScan. We observed that the new ranking method performs well and consistent, and the first validated targets are elements of Pareto fronts at a relatively early stage of the recurrent procedure, which encourages further research towards a higher-dimensional analysis of Pareto fronts.
在过去的十年中,已经开发出了多种 microRNA 靶标预测方法,并且许多方法都在不断改进和适应最近对 miRNA-mRNA 相互作用的见解。在典型情况下,不同的方法会返回不同的假定靶目标的排名,即使排名缩小到与特定疾病或细胞类型相关的选定 mRNAs。对于实验验证,然后很难决定以哪种顺序处理预测的 miRNA-mRNA 结合,因为每个验证都是一项费力的任务,因此只能分析有限数量的 mRNAs。我们提出了一种新的排名方案,该方案结合了几种方法的排名预测,并且与标准阈值方法不同,它利用了多目标优化中定义的 Pareto 前沿的概念。在本研究中,我们尝试通过将新的排名方案应用于 hsa-miR-21、hsa-miR-125b 和 hsa-miR-373 以及由 PITA 和 RNAhybrid 提供的预测分数来证明这一概念。分数被解释为一个双目标优化问题,Pareto 前沿的元素通过 STarMir 分数进行排名,然后在从基本预测分数集中删除排名最高的 mRNAs 后重新计算 Pareto 前沿。该方法在这三个 miRNA 的验证靶标上进行了评估,并将排名与 DIANA-microT 和 TargetScan 的分数进行了比较。我们观察到,新的排名方法表现良好且一致,并且在反复过程的早期阶段,第一批验证的靶标就是 Pareto 前沿的元素,这鼓励对 Pareto 前沿进行更高维的分析进行进一步的研究。